Total Payments
$43,810
2022 Payments
$82.61
Companies
24
Transactions
293
Medicare Patients
325
Medicare Billing
$26,907
Payment Breakdown by Category
Other$30,950 (70.6%)
Food & Beverage$7,316 (16.7%)
Travel$5,539 (12.6%)
Education$4.54 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,950 | 17 | 70.6% |
| Food and Beverage | $7,316 | 257 | 16.7% |
| Travel and Lodging | $5,539 | 18 | 12.6% |
| Education | $4.54 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $27,340 | 68 | $0 (2021) |
| Amarin Pharma Inc. | $11,524 | 35 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,268 | 17 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $1,072 | 58 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $1,019 | 37 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $270.01 | 14 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $258.49 | 14 | $0 (2021) |
| PFIZER INC. | $130.53 | 7 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $121.15 | 7 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $88.61 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $82.61 | 4 | Novartis Pharmaceuticals Corporation ($37.94) |
| 2021 | $1,049 | 51 | Amarin Pharma Inc. ($230.60) |
| 2020 | $11,980 | 41 | Amarin Pharma Inc. ($11,231) |
| 2019 | $1,124 | 44 | Janssen Pharmaceuticals, Inc ($291.50) |
| 2018 | $8,206 | 68 | Amgen Inc. ($6,935) |
| 2017 | $21,368 | 85 | Amgen Inc. ($20,076) |
All Payment Transactions
293 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/23/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/09/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: Cardio-renal | ||||||
| 04/19/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Diabetes | ||||||
| 03/29/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Cardio-renal | ||||||
| 12/01/2021 | Althera Pharmaceuticals LLC | Roszet (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Cardiovascular | ||||||
| 11/29/2021 | Althera Pharmaceuticals LLC | Roszet (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Cardiovascular | ||||||
| 11/25/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/11/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.05 | General |
| Category: Cardiovascular | ||||||
| 11/08/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Cardio-renal | ||||||
| 10/20/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/30/2021 | Althera Pharmaceuticals LLC | Roszet (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Cardiovascular | ||||||
| 09/29/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/01/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/05/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/01/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/28/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Cardiovascular | ||||||
| 06/11/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Cardiovascular | ||||||
| 06/02/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.09 | General |
| Category: Cardiovascular | ||||||
| 05/27/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/20/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Cardiology | ||||||
| 05/20/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: Cardiovascular | ||||||
| 05/19/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 24 | $3,000 | $1,174 |
| 2022 | 2 | 36 | 61 | $11,525 | $3,091 |
| 2021 | 5 | 107 | 127 | $32,725 | $9,612 |
| 2020 | 7 | 168 | 194 | $49,950 | $13,031 |
Total Patients
325
Total Services
406
Medicare Billing
$26,907
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 24 | $3,000 | $1,174 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 49 | $6,125 | $2,399 | 39.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 12 | 12 | $5,400 | $692.28 | 12.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 46 | $5,750 | $3,611 | 62.8% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 17 | 17 | $15,300 | $3,369 | 22.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 15 | $1,875 | $1,185 | 63.2% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg, includes recording, scanning analysis with report | Office | 2021 | 13 | 14 | $6,300 | $1,029 | 16.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 34 | 35 | $3,500 | $417.31 | 11.9% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 22 | 23 | $20,700 | $4,383 | 21.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 34 | 48 | $6,000 | $2,855 | 47.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 24 | $3,000 | $2,236 | 74.5% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2020 | 20 | 21 | $9,450 | $1,298 | 13.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 16 | 16 | $4,000 | $1,240 | 31.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 48 | 50 | $5,000 | $713.25 | 14.3% |
| 93228 | Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days | Office | 2020 | 12 | 12 | $1,800 | $306.22 | 17.0% |
About Dr. Constantine Kosmas, M.D
Dr. Constantine Kosmas, M.D is a Cardiovascular Disease healthcare provider based in Astoria, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407855075.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Constantine Kosmas, M.D has received a total of $43,810 in payments from pharmaceutical and medical device companies, with $82.61 received in 2022. These payments were reported across 293 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,950).
As a Medicare-enrolled provider, Kosmas has provided services to 325 Medicare beneficiaries, totaling 406 services with total Medicare billing of $26,907. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Astoria, NY
- Active Since 07/18/2005
- Last Updated 12/13/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407855075
Products in Payments
- Repatha (Biological) $26,955
- Vascepa (Drug) $11,524
- XARELTO (Drug) $1,161
- JARDIANCE (Drug) $1,040
- ENTRESTO (Drug) $1,004
- Corlanor (Drug) $384.77
- ELIQUIS (Drug) $335.43
- PRALUENT ALIROCUMAB INJECTION (Biological) $244.89
- PRADAXA (Drug) $198.68
- BRILINTA (Drug) $121.15
- Cardiac Monitoring Suite (Device) $97.64
- TRULICITY (Drug) $80.85
- NEXLETOL (Drug) $80.16
- VERQUVO (Drug) $77.13
- Veltassa (Drug) $70.15
- Kerendia (Drug) $67.42
- PRALUENT (Drug) $63.60
- Roszet (Drug) $60.04
- CHANTIX (Drug) $53.59
- TRADJENTA (Drug) $29.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Astoria
Dr. Ali Haider, M.d, M.D
Cardiovascular Disease — Payments: $512,070
Cardiovascular Disease $512,070
Dr. Sameet Palkhiwala, Md, MD
Cardiovascular Disease — Payments: $4,464
Cardiovascular Disease $4,464
Allison Selby, D.o, D.O
Cardiovascular Disease — Payments: $4,129
Cardiovascular Disease $4,129
Demetrios Georgiou, M.d, M.D
Cardiovascular Disease — Payments: $1,736
Cardiovascular Disease $1,736
Dr. Tarek Mousa, Md, Phd, MD, PHD
Cardiovascular Disease — Payments: $1,269
Cardiovascular Disease $1,269
Rupa Iyengar-Kapuganti, Md, MD
Cardiovascular Disease — Payments: $1,210
Cardiovascular Disease $1,210